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Abstract
Background
According to the “World Cancer Research Fund” and the “American Institute of Cancer Re-
search” (WCRF/AICR) one in four cancer cases could be prevented through a healthy diet,
weight control and physical activity.
Objective
To explore the association between the WCRF/AICR recommendations and risk of
breast cancer.
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Methods
During the period 2006 to 2011 we recruited 973 incident cases of breast cancer and 973
controls from 17 Spanish Regions. We constructed a score based on 9 of the WCRF/AICR
recommendations for cancer prevention:: 1)Maintain adequate body weight; 2)Be physically
active; 3)Limit the intake of high density foods; 4)Eat mostly plant foods; 5)Limit the intake
of animal foods; 6)Limit alcohol intake; 7)Limit salt and salt preserved food intake; 8)Meet
nutritional needs through diet; S1)Breastfeed infants exclusively up to 6 months. We ex-
plored its association with BC by menopausal status and by intrinsic tumor subtypes (ER
+/PR+ & HER2-; HER2+; ER&PR-&HER2-) using conditional and multinomial logistic
models respectively.
Results
Our results point to a linear association between the degree of noncompliance and breast
cancer risk. Taking women who met 6 or more recommendations as reference, those meet-
ing less than 3 showed a three-fold excess risk (OR=2.98(CI95%:1.59-5.59)), especially for
postmenopausal women (OR=3.60(CI95%:1.24;10.47)) and ER+/PR+&HER2- (OR=3.60
(CI95%:1.84;7.05)) and HER2+ (OR=4.23(CI95%:1.66;10.78)) tumors. Noncompliance of
recommendations regarding the consumption of foods and drinks that promote weight gain
in premenopausal women (OR=2.24(CI95%:1.18;4.28); p for interaction=0.014) and triple
negative tumors (OR=2.93(CI95%:1.12-7.63)); the intake of plant foods in postmenopausal
women (OR=2.35(CI95%:1.24;4.44)) and triple negative tumors (OR=3.48(CI95%:1.46-
8.31)); and the alcohol consumption in ER+/PR+&HER2- tumors (OR=1.52 (CI95%:1.06-
2.19)) showed the strongest associations.
Conclusion
Breast cancer prevention might be possible by following the “World Cancer Research Fund”
and the “American Institute of Cancer Research” recommendations, even in settings like
Spain, where a high percentage of women already comply with many of them.
Introduction
Breast cancer (BC) is the most common cancer among women worldwide and, in spite of the
continuous improvements in BC prognosis, this tumor constitutes the leading cause of cancer
death among women in medium and high income countries [1–4]. Figures in Europe indicate
that the absolute number of new diagnosis and deaths due to this disease continues to increase.
Comparing the most recent estimates from 2008 and 2012, breast cancer incidence has risen
from 421.000 [5] cases to 458.337 [6] in Europe with the subsequent personal and economic
consequences. Recently published data reveals that, in 2009, the European health-care system
expended €6.73billion in the diagnosis and treatment of BC, leading the ranking in terms of ex-
penditure (13% of all cancer-related health-care costs) [7]. According to the scientific evidence,
only a 5–10% of all cancer cases are due to genetic defects and the remaining 90–95% are attrib-
utable to environmental and lifestyle factors. Concretely, tobacco, diet, infection and obesity,
contribute approximately 25–30%, 30–35%, 15–20% and 10–20% respectively, providing
major opportunities for prevention [8]. A recent study about research gaps for BC prevention
WCRF/AICR Recommendations and Breast Cancer Risk
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highlights, among the main critical needs, the implementation of sustainable changes in life-
style based on diet, exercise and weight [9]. In this context, the “World Cancer Research Fund”
(WCRF) and the “American Institute of Cancer Research” (AICR) issued in 2007, 8 general
and 2 special recommendations on diet, physical activity and weight management for cancer
prevention based on the available evidence[10,11]: 1)Maintain adequate body weight; 2)Be
physically active; 3)Limit the intake of high density foods; 4)Eat mostly plant foods; 5)Limit the
intake of animal foods; 6)Limit alcohol intake; 7)Limit salt and salt preserved food intake; 8)
Meet nutritional needs through diet; S1)Breastfeed infants exclusively up to 6 months.
To our knowledge, only four studies have explored the specific association between these
recommendations and BC risk [12–15] and none of them has classified the cases by tumor sub-
type considering hormonal receptors and the Human Epidermal Growth Factor Receptor 2
(HER2) status.
The objective of this study was to explore the association between WCRF/AICR recommen-
dations and BC by menopausal status and pathological tumor subtype in Spain, a country tra-
ditionally characterized by healthy lifestyle habits.
Methods
EpiGEICAM case-control study
As we previously described [16], EpiGEICAM is a Spanish case-control study that recruited,
between 2006 and 2011, 1017 incident cases of BC diagnosed in the Oncology departments of
23 hospitals members of the Spanish Breast Cancer Research Group (GEICAM: http://www.
geicam.org) located in 9 of the 17 Spanish Regions. The participant oncologists invited the
cases to participate in the moment of diagnosis. The inclusion criteria for cases were: age be-
tween 18 and 70 years old, agreement to participate and ability to understand and answer the
questionnaire. Women previously diagnosed with breast cancer and women who were unable
to answer the questionnaire due to health, language or educational issues were excluded. Each
case was matched with a healthy control of similar age (± 5 years), selected from cases’ in-law
relatives, friends, neighbors, or work colleagues residing in the same town.
Cases were sub classified by the following intrinsic subtypes based on local pathology re-
ports: [17] 1) HER2- tumors (Estrogen Receptor (ER)+ or Progesterone Receptor (PR)+ with
HER2-), 2) HER2+ tumors (HER2+ irrespective of ER or PR results); and 3) Triple negative tu-
mors (ER-&PR-&HER2-). ER, PR and HER2 positivity were defined according to ASCO/CAP
guidelines [18,19].
The EpiGEICAM study was approved by the Ethics Committees of all 23 participating hos-
pitals (S4 Table). All participants signed an informed consent and patient information was
anonymized and de-identified prior to analysis.
Measurements
Cases and controls completed a structured and self-administered questionnaire collecting in-
formation on demographic and anthropometric characteristics, personal, family, obstetric and
gynecologic history, physical activity and diet. Postmenopausal status was defined as absence
of menstruation in the last 12 months. Dietary intake in the last five years was estimated using
a 117-item semi-quantitative food frequency questionnaire (FFQ) [20] adapted to and validat-
ed in different Spanish adult populations [21,22]. Upon agreement to participate, cases where
invited to meet with the trained recruiters (nurses and other sanitary staff) that explained the
study, proportionate the questionnaire and gave basic instructions to fill it in. In order to mini-
mize the effect of recall bias, women were asked to respond within the following days and deliv-
er the completed questionnaire in person within three months. They were also asked to bring
WCRF/AICR Recommendations and Breast Cancer Risk
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their selected control in the next visit to follow the same process. The questionnaire was jointly
reviewed by the participant and the interviewer in each center, who clarified those questions
that the participant was not able to answer by herself.
The WCRF/AICR score was constructed following the 8 general and 2 special recommenda-
tions fromWCRF/AICR report on food, nutrition and physical activity and the Continuous
Update Project (CUP) for cancer prevention based on the available evidence [10,11]. Briefly,
the score was based in 9 of the 10 recommendations: 1) Maintain adequate body weight; 2) Be
physically active; 3) Limit the intake of high density foods; 4) Eat mostly plant foods; 5) Limit
the intake of animal foods; 6) Limit alcohol intake; 7) Limit salt and salt preserved food intake;
8) Meet nutritional needs through diet; S1) Breastfeed infants exclusively up to 6 months. The
special recommendation S2) for cancer survivors was not applicable to this population. A max-
imum score of 1 was assigned when the recommendation was fully met, an intermediate value
of 0.5 when the recommendation was not far from being met and 0 points otherwise (Table 1).
For the recommendations based in various subrecommendations, the final mark was calculated
as the average of the subscores. The total mark was calculated as the sum of the scores in all 9
recommendations. Therefore, the WRCF/AICR score ranges from 0 to 9 and represents the
minimum number of recommendations meet for each woman. The index was grouped in 5 cat-
egories [0–3[, [3–4[, [4–5[, [5,6 [and [6, 9]. The cut offs were defined as in Romaguera et al.
[13] with the only exception of a wider last category. Categories “0–3” and “>3 to<4” were
collapsed when the number of cases was smaller than 5.
Statistical analysis
Smoking habit (<1%), age at first delivery (5%) and education (<1%) contained missing val-
ues. In order to obtain unbiased estimates of the effect of the recommendations using the infor-
mation provided by all case-control pairs, missing values were imputed using multiple
imputation with chained equations [23]. As explained in Royston et al [24] the chained equa-
tions method imputes missing values in different steps: Initially, all missing values are filled at
random. The first variable with at least one missing value, smoking say, is then regressed on
the other variables including those with missing values imputed at random in the initial step
(BMI, physical activity, age at first delivery, education and age at menarche) and another set of
potential explanatory variables that do not contain missing (menopausal status, age, number of
children, hip and waist circumferences, bra size, calories, alcohol consumption and case/con-
trol status). The estimation is restricted to individuals with observed values for smoking and
the missing values are replaced by simulated draws for the posterior predictive distribution of
smoking. The next variable with missing values, say age at menarche, is regressed on all the
other variables, included imputed values of smoking and restricting estimation to individuals
with observed values for the variable to impute. Again, missing values for age at menarche are
replaced by draws from the posterior predictive distribution. This process is repeated until a
stable imputation is found for all values of all variables. Following this process we created five
imputed data sets that were used for subsequent analyses. The final effect association is a
weighted average of the effects found in these five datasets.
The association of the WCRF/AICR score with BC risk was evaluated using conditional lo-
gistic regression models with robust estimation of standard errors, both in categories and as a
continuous term (considering the risk associated to one-unit decrease in the score). Same mod-
els where used to explore the association between the accomplishment of the individual recom-
mendations and BC risk. All models included the following potential confounders: total calorie
intake, smoking habit, age at first delivery, education, history of breast problems, family history
of BC and menopausal status. Models for noncompliance of individual recommendations were
WCRF/AICR Recommendations and Breast Cancer Risk
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Table 1. Operationalization of theWCRF/AICR in a score (0–9) using EpiGEICAM data.
WCRF/AICR recommendations Personal recommendations Operationalizationa Scoring
1) Maintain adequate body weight: Be as lean
as possible without becoming underweight
Self-reported BMI (in kg/m2) 18y 18.5–24.9 1
1a) Ensure that body weight through childhood and adolescence
growth projects towards the lower end of normal BMI range at age
18y
25–29.9 0.5
<18.5 or > = 30 0
BMI one year ago 18.5–24.9 1
1b) Maintain body weight within the normal range from age 18y 25–29.9 0.5
<18.5 or > = 30 0
Weight gain per 10 years from 18yo 2.5 Kg/10years 1
1c) Avoid weight gain and increases in waist circumference
throughout adulthood
2.5–5 Kg/10years 0.5
>5Kg/10years 0
2) Be physically active as part of your
everyday life
Self-perception of physical activity during the last year
2a) Be moderately physically active, equivalent to brisk walking, for
> = 30min every day;
Vigorous 1
2b) As fitness improves, aim for > = 60 min of moderate or for > =
30 min of vigorous physical activity every day;
Moderate 0.5
2c) Limit sedentary habits such as watching television Low 0
3) Limit consumption of energy-dense foods;
avoid sugary drinks
Energy-dense foods b < = 125kcal/100 g 1
3a) Consume energy-dense foods sparingly 125-175kcal/100 g 0.5
>175lcal/100 g 0
Sugary drinks intake g c 0 g/d 1
3b) Avoid sugary drinks < = 250 g/d 0.5
>250 g/d 0
Fast food intake g d <18 g/d 1
3c) Consume fast foods sparingly 18–42 g/d 0.5
>42 g/d 0
4) Eat mostly foods of plant origin Fruits and vegetables e > = 400 g 1
4a) eat> = 5 portions/servings(> = 400 g) of a variety of non-
starchy vegetables and fruit every day
200–400 g 0.5
<200 g 0
Cereals, whole grain bread and legumes f > = 64 g/d 1
4b) Eat relatively unprocessed cereals (grains) and/or pulses
(legumes) with every meal
24–64 0.5
<24 0
White bread, pasta and rice g <91 g/d 1
4c) Limit refined starchy food 91–144 g/d 0.5
> = 144 0
4d) people who consume starchy roots or tubers as staples should
also ensure sufficient intake of no starchy vegetables, fruit and
pulses (legumes)
Not applicable to this
population
5) Limit intake of red meat and avoid
processed meat
Red (R) and processed (P) meath R+P<500g/wk and
P<3g/d
1
People who eat red meat should consume <500g/wk and very few,
if any, processed meat
R+P<500g/wk and P 3-
50g/d
0.5
R+P> = 500g/wk or P>
= 50 g/d
0
6) Limit alcoholic drinks Ethanol intake i < = 10 g/d 1
If alcoholic drinks are consumed, limit consumption to < = 1 drink/d 10–20 g/d 0.5
> = 20 g/d 0
(Continued)
WCRF/AICR Recommendations and Breast Cancer Risk
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also adjusted for the overall score obtained by adding up all the individual recommendations
except the one under study. This approach was selected instead of adjusting for individual rec-
ommendations to avoid introducing collinearity in the models caused by the high dependence
among them. Possible differences by menopausal status were assessed using interaction terms
(1 df) between WRCF/AICR score/individual recommendations and menopausal status.
Multinomial logistic regression models were used to evaluate the association of the WCRF/
AICR score/individual recommendations with each of the aforementioned intrinsic BC sub-
types. These models were adjusted for age, hospital, and the same set of potential confounders
described above.
The Wald test was used to compare the dose-response effect for each tumor subtype.
Assuming a causal relationship between the score WCRF/AICR and BC risk, the population
attributable fraction (PAF%) was calculated using Levi's formula [25] to estimate the propor-
tion of total cancer in this population that hypothetically would not have occurred if all partici-
pants were in the highest category of the score (6 or more recommendations met). Confidence
intervals for PAF were computed using bootstrap with 1000 iterations.
Table 1. (Continued)
WCRF/AICR recommendations Personal recommendations Operationalizationa Scoring
7) Limit consumption of salt and salt
preserved food. Avoid moldy cereals (grains
or pulses)
Cold meat & salted/smoked fishj < = 7 g/d 1
7 a) Avoid slat-preserved, salted or salty foods. Preserve foods
without using salt
7–22 g/d 0.5
>22 g/d 0
Sodium <2.4 1
7b) Limit consumption of processed foods with added salt to
ensure an intake of sodium <2.4 g/d
2.4–3 0.5
> = 3 0
7c) Do not eat moldy cereals (grains) or pulses (legumes) Insufficient data
available
8) Meet nutritional needs through diet alone Supplement use No 1
8a) Dietary supplements are not recommended for cancer
prevention
1 /d 0.5
>1/d supplement 0
WCRF/AICR especial recommendations
S1) Breastfeed infants exclusively up to 6
months
Cumulative breastfeeding > = 6 mo 1
Aim to breastfeed infants exclusively up to 6 months and continue
with complementary feeding thereafter
>0 to <6 mo 0.5
No breastfeeding 0
S2) Cancer survivors. Follow the
recommendations for cancer prevention
Not applicable to this
population
a Cutoffs provided in the “World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of
Cancer: a Global Perspective. Washington DC: AICR, 2007. In. 2007; 289–295.” or in the distribution of the data when the cut point was not specified
(3c;4b;4c;7a;7b).
b Energy intake for all foods considered.
c Sugary drinks: juices and other sugared beverages.
d Fast food: Fried potatoes, crisps, pizza, chicken and Serrano ham croquette, mayonnaise, tomato sauce, ketchup.
e Fruits and vegetables: Orange, mandarin, banana, apple, pear, peach, nectarine, apricot, watermelon, melon, grapes, plums or prunes (dried or fresh),
kiwi, spinach, chard, lettuce, endive, escarole, tomato, eggplant, zucchini, cucumber, pepper, artichoke, carrot, pumpkin, cooked cabbage, cauliflower or
broccoli, onion, green beans, asparagus, corn and garlic.
f Cereals, whole grain bread and legumes: Whole-grain bread and partial whole-grain bread, breakfast cereals and legumes.
g Refined Grains: White-flour bread, rice, pasta.
h Red and processed meat: Pork, beef, lamb, liver (beef, pork or chicken), entrails, hamburger, cold meat, sausages, bacon, pâte, foie-gras.
i Alcohol: Measured as total ethanol intake coming from wine, beer and spirits.
j Serrano ham and other cold meat and smoked and salt preserved fish.
doi:10.1371/journal.pone.0126096.t001
WCRF/AICR Recommendations and Breast Cancer Risk
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Fractional polynomials were also used to explore the shape of the dose-response association
between the score and BC risk [26].
Finally, a complete case analysis [23] was carried out for all models to check the validity of
the imputation.
Analyses were performed in 2014 using STATA/MP 12.0 software.
Results
After excluding 44 case-control pairs (n = 88) because of implausible reported energy intakes
(<750 or>4500 kcal/day) [27] information in either the case or the control, final analyses
were based on 973 cases-control pairs aged 22 to 71.
Compared to controls, BC cases seemed to accomplish less WCRF/AICR recommendations
have higher age at first delivery, a lower education level, a larger proportion of breast problems
and of family history of BC and a higher calorie intake (Table 2).
Table 3 summarizes the results for the association between the WCRF/AICR scores and in-
dividual recommendations and BC risk by menopausal status. Despite the fact that the BC risk
appeared to increase linearly with the decrease in the WCRF/AICR score, the categorical analy-
ses showed the most significant risk for women with a score below 4. Women that accomplish
only 3 recommendations showed a two-fold increased risk of BC than women in the upper cat-
egory (OR = 2.09 (CI95%:1.46;2.99)) and women meeting less than 3 recommendations
showed a three-fold increase in such a risk (OR[0–3[vs[6–9] = 2.98 (CI95%:1.59–5.59)). The risk
was higher in postmenopausal (OR[0–3[vs[6–9] = 3.60 (CI95%:(1.24;10.47)) than in premeno-
pausal women (OR[0–3[vs[6–9] = 2.66 (CI95%:(1.23;5.76)), but confidence intervals overlap and
the p-value for the interaction term in the continuous model was not statistically significant.
The proportion of preventable cases of BC in this population by following 6 or more recom-
mendations was estimated at around 30% for all women and also by menopausal status groups.
Regarding specific items, diet related individual recommendations showed the strongest associ-
ations. In fact, noncompliance with recommendation 3 “Limit the intake of high density food”
had an excess risk of 1.86 (CI95%:1.15;3.01), especially in premenopausal women (OR = 2.24
(CI95%: (1.18–4.28); p for interaction = 0.014), while a low intake of plant foods was also asso-
ciated with BC (OR = 1.65 (CI95%:(1.08;2.57)), particularly among postmenopausal women
(OR = 2.35 (CI95%:(1.24;4.44)), although the p-value for heterogeneity was not significant.
The odds ratio of BC for women with alcohol consumption above the recommended was over
1.30 in all cases, however, none of these estimations showed statistical significance, probably
given to the fact that most women (94% of controls and 95% of cases) meet totally or partially
this specific recommendation.
Regarding the analyses by pathological subtype, even though no statistically significant dif-
ferences were observed between subtypes, the increased risk for the lack of compliance with the
WCRF/AICR recommendations was especially high for women with ER+/PR+&HER2- (OR[0–
3[vs[6–9] = 3.60 (CI95%:(1.84;7.05) and OR[3–4[vs[6–9] = 2.18 (CI95%:(1.50;3.16)) and HER+ tu-
mors (OR[0–3[vs[6–9] = 4.23 (CI95%:(1.66;10.78)). Triple negative tumors were also associated
with the WCRF/AICR score in the lower category (OR[0–4[vs[6–9] = 2.32 (CI95%:(1.20;4.46)).
The highest preventable effect of the WCRF/AICR guidelines was observed for ER+/PR
+&HER2- (PAF95%CI: 35% (17%;53%)) and HER+ (PAF95%CI:34% (5%;62%)) tumors while
such effect was not significant for the triple negative subtype. Again, for individual items, diet-
related recommendations seemed to be the most important, particularly the consumption of
foods and drinks that promote weight gain above the recommended which showed OR ranging
from 1.68 for ER+/PR+/HER2- tumors to 2.93 for triple negative tumors, though the p-value
for heterogeneity was not statistically significant. Low consumption of plant foods seemed to
WCRF/AICR Recommendations and Breast Cancer Risk
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Table 2. DistributionWCRF/AICR score and individual recommendations and other baseline characteristics for cases and controls.
Co/Ca Pairs Controls Cases P
Score n(%) 973/973 973 <0.001
6 to 9 265 (27%) 185 (19%)
5 to <6 308 (32%) 291 (30%)
4 to <5 266 (27%) 287 (29%)
3 to <4 117 (12%) 172 (18%)
0 to <3 17 (2%) 38 (4%)
Score mean(sd) 973/973 973 5.21 (1.14) 4.93 (1.17) <0.004
Recommendations Mean (sd)
1) Maintain adequate body weight 912/902 852 0.63(0.32) 0.60(0.33) 0.036
2) Be physically active 907/893 834 0.45(0.39) 0.42(0.41) 0.085
3) Limit the intake of high density foods 973/973 973 0.64(0.23) 0.60(0.24) <0.001
4) Eat mostly plant foods 973/973 973 0.61(0.23) 0.58(0.24) 0.003
5) Limit the intake of animal foods 973/973 973 0.32(0.29) 0.29(0.29) 0.033
6) Limit alcohol intake 973/973 973 0.88(0.28) 0.85(0.30) 0.035
7) Limit salt and salt preserved food intake 973/973 973 0.50(0.34) 0.45(0.34) 0.001
8) Meet nutritional needs through diet 973/973 973 0.69(0.38) 0.68(0.39) 0.376
S1) Breastfeed infants exclusively up to 6 months 816/800 681 0.50(0.44) 0.47(0.44) 0.246
Smoking n(%) 971/969 967 0.711
Never smoker 385 (40%) 395 (41%)
Former smoker +6months 261 (27%) 267 (27%)
Smoker or former smoker <6 months 325 (33%) 307 (32%)
Unknown 2 (0%) 4 (0%)
Age at first delivery n(%) 887/967 882 <0.001
<20 45 (5%) 49 (5%)
20–24 208 (21%) 229 (24%)
25–29 266 (27%) 258 (27%)
>25 148 (15%) 216 (22%)
Nulliparous 220 (23%) 215 (22%)
Unknown 86 (9%) 6 (1%)
Education n(%) 969/969 966 0.003
Primary school or less 159 (16%) 210 (22%)
Secondary School 491 (50%) 503 (52%)
University 319 (33%) 256 (26%)
Unknown 4 (0%) 4 (0%)
History of breast problems n(%) 973/973 973 0.047
No 796 (82%) 761 (78%)
Yes 177 (18%) 212 (22%)
Family history of breast cancer n(%) 973/973 973 0.012
None 782 (80%) 728 (75%)
2nd degree 105 (11%) 129 (13%)
1st degree 86 (9%) 116 (12%)
Menopausal Status n(%) 973/973 973 0.084
Premenopausal 513 (53%) 551 (57%)
Postmenopausal 460 (47%) 422 (43%)
Kcal intake mean(sd) 973/973 973 1897 (628) 1990 (615) 0.001
doi:10.1371/journal.pone.0126096.t002
WCRF/AICR Recommendations and Breast Cancer Risk
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be specifically associated with triple negative tumors (OR = 3.48 (CI95%:(1.46–8.31)), with a p-
value of heterogeneity of 0.148 while consumption of alcoholic drinks was only significantly as-
sociated with ER+/PR+&HER2- tumors (OR = 1.52 (CI95%:(1.06–2.19)) (Table 4).
The exploration of non-linear associations using fractional polynomials revealed that the
linear model was the best fit when a continuous association was found (S1 Fig).
Sensitivity analyses gave similar results leading to the same conclusions (S1 and S2 Tables).
Discussion
Summary
Our results suggest that WCRF/AICR recommendations may help to prevent overall BC risk,
especially among postmenopausal women and women with ER+/PR+&HER2- or HER
+ tumor subtypes. Diet related individual recommendations seemed to be the factors more
strongly associated with BC risk, especially a high consumption of high density foods or alcohol
and the low intake of plant foods.
Comparison with other studies
To our knowledge only four studies have explored the association between BC risk and the
WCRF/AICR recommendations: two in the US, one in Canada and another using the Europe-
an EPIC cohort, showing similar results to ours [12–15]. All of them report a significant linear
negative trend for the association between the number of recommendations met and BC risk
and two of them also identified women that meet 3 or less recommendations as the higher risk
group [13,14]. Two of these studies also explored the specific relationship between individual
recommendations and BC risk [12,15] and the authors found the strongest associations with
the recommendations related to body fatness and food and alcohol intake that go in the same
direction as ours.
Specific literature exploring the individual items that compose the WCRF/AICR score in re-
lation with breast cancer, has pointed through a negative or non-significant effect of BMI or
physical activity on the incidence of BC in premenopausal women and a positive association
with postmenopausal breast cancer [10,11,28–30]. Our results, though not statistically signifi-
cant, point in the same direction. Concerning diet and breast cancer, strong evidence is only
available for the negative effect of alcohol consumption [10,11,31]. However some studies in
low and medium income countries with greater dietetic variability suggested other interesting
associations [31]. In this sense, various studies support our finding of a protective effect of plant
foods intake against BC [32,33], particularly against RE-PR- tumors [34,35]. This is in agree-
ment with the stronger effect we observed for triple negative tumors. Regarding the influence of
foods and drinks that promote weight gain on BC development, to our knowledge, no specific
studies have explored this association. The purpose of the third recommendation is to prevent
cancer risk through a better control of body weight reducing the intake of energy-dense foods
[10,11,36]. However, it is possible that the detrimental effect of this type of foods goes beyond
the excess risk associated with an increase in body-weight, as our results suggest. Energy-dense
foods not only include high-fat dietary products, but also highly sugared and processed foods
that might have an effect on BC risk. The consumption of this type of food increases the risk es-
pecially in premenopausal women with higher adherence to a western-style diet [27].
The evidence of an association between consumption of red meat and processed food and
BC is still weak [33,37,38], but it is in agreement with our results regarding recommendations 5
and 7. Despite the fact that alcohol is the only nutritional factor for which strong evidence of a
positive association exists [10,11,31], we only identified a positive significant association with
alcohol for women with ER+/PR+&HER2- tumors, even though results point through a
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positive association for BC in general. Our women did not report a high consumption of alco-
hol (only 79 cases and 61 controls reported an ethanol intake20g/d) therefore differences be-
tween women in this case might be insufficient to obtain significant associations with the
current sample size. Contrary to what is known for other tumors, vitamin supplementation has
not been negatively associated with BC. In fact, some studies about supplementation with nu-
trients like vitamin C, D and E or calcium, to prevent BC have been published but the evidence
is still insufficient to reach conclusions [39–42]. Finally, breast feeding appears to be a well-es-
tablished protective factor for BC [10,11], but, we did not find a significant association in the
analyses. In our sample only 28% of women did not breastfeed, being 97% of them nulliparous.
These proportions might be too small to obtain significant results.
Regarding the potential preventability of the WCRF/AICR recommendations observed in
our study, it is in concordance with the results published in the Policy and Action for Cancer
Prevention Report [36] whose estimates for USA, UK, Brazil and China were 38%, 42%, 28%
and 20% respectively.
Limitations and Strengths
Recall bias is always a concern in case-control studies; however, the validity and reproducibility
of FFQ was satisfactory [21,22] and the strength of the associations deemed it unlikely that our
findings are a result of this bias. Secondly, statistical power was limited in the subgroup analy-
ses by intrinsic tumor subtype and therefore the results should be interpreted with caution. On
the other hand, the matching design resulted in closely related cases and controls which would
bias the OR towards the null effect. In spite of these limitations, we were able to detect a consis-
tent dose-response gradient for the association between BC and WCRF/AICR score, even in
the stratified and subgroup analyses.
Except for the cases of the specific subrecommendations related to moldy cereals or pulses,
we were able to operationalize all general and specific WCRF/AICR recommendations applicable
to this population. No previous studies have been able to operationalize all the recommendations
with their data and only one was able to explore the individual association between BC risk and 6
out of the 9 recommendations. On the other hand, this is the first study that explores such associ-
ations by menopausal status and BC pathological subtype including ER, PR and HER2 status.
Finally, Spain is a country that has traditionally maintained healthy dietary habits. In fact,
almost 60% of the control population met 5 or more recommendations and 90% of our women
accomplish somehow the most important recommendations on food (R1 and R4) and alcohol
consumption (R6) (S4 Table). However, our results suggest that our women can still benefit
from a greater adherence to the WCRF/AICR recommendations.
Conclusions
BC prevention might be possible by following the WRCF/AICR recommendations, even in set-
tings like Spain, where a high percentage of women already comply with many of them. Despite
the fact that especial benefit can be obtained by avoiding the consumption of foods and drinks
that promote weight gain, limiting alcohol intake and increasing the consumption of plant
foods, our results indicate that a good level of satisfaction with most of the recommendations is
more important than any single recommendation.
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